Biomechanical Properties of Achilles Tendon in Diabetic vs. Non-diabetic Patients

 

 Buy Article Permissions and Reprints

Abstract

Background/objectives: Structural and functional impairments of the Achilles tendon in diabetic patients has the potential to contribute to ulcer formation through altered foot mechanics. This study aimed to examine the biomechanical and histopathological alterations in Achilles tendon specimens from diabetic vs. non-diabetic individuals.

Materials and methods: 42 Achilles tendon samples obtained from patients treated with below-knee or above-knee amputation for chronic diabetic foot ulcers (n=21) or for non-diabetic conditions (n=21) were included. A tensile test was performed for each tendon and a stress vs. strain graft was obtained to calculate following biomechanical parameters: elasticity (Young modulus), load, stiffness, toughness, energy, strain, elongation and tenacity. Groups were also compared with regard to histopathological findings (inflammatory cell infiltration, collagen organization, and degeneration).

Results: Non-diabetic tendons exhibited a superior biomechanical profile over diabetic tendons with regard to the following biochemical parameters: elasticity, maximum load, stiffness, toughness, load, energy, strain and elongation at break point, tenacity, and strain at automatic load drop (p<0.05 for all comparisons). Diabetic tendons had mild impairment of collagen organization and focal collagen degeneration, whereas neither diabetic nor non-diabetic tendons had inflammatory cell infiltration.

Conclusion: The structural and functional alterations associated with diabetes adversely affect the biomechanical properties of the Achilles tendon, potentially acting together with neuropathy and ischemia in the development of diabetic foot ulcers.

• References

• 1 The Expert Commitee on diagnosis and classification of diabetes mellitus: Report of the Expert Commitee on diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197
  CrossrefPubMedGoogle Scholar
• 2 Levin ME. Pathogenesis and management of diabetic foot. In: Levin ME, O’Neal LW, Bowker JH. (eds.) Diabetic foot. Fifth ed. St. Louis: Mosby Year Book Inc; 1993: 17-60
  Google Scholar
• 3 Brodsky JW. Evaluation of the diabetic foot. Instr Course Lect 1999; 48: 289-303
  PubMedGoogle Scholar
• 4 Gavin LA. A comprehensive approch to sidestep diabetic foot problems. The Endocrinologist 1993; 3: 191
  CrossrefPubMedGoogle Scholar
• 5 Akturk M, Ozdemir A, Maral I et al. Evaluation of Achilles tendon thickening in type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2007; 115: 92-96
  Article in Thieme ConnectPubMedGoogle Scholar
• 6 D’Ambrogi E, Giacomozzi C, Macellari V et al. Abnormal foot function in diabetic patients: the altered onset of Windlass mechanism. Diabet Med 2005; 22: 1713-1719
  CrossrefPubMedGoogle Scholar
• 7 Abdel MA. Impact of achilles tendon lengthening (ATL) on the diabetic plantar forefoot ulceration. Egypt J Plast Reconstr Surg 2006; 30: 43-48
  PubMedGoogle Scholar
• 8 de Oliveira RR, de Lira KD, Silveira PV et al. Mechanical properties of achilles tendon in rats induced to experimental diabetes. Ann Biomed Eng 2011; 39: 1528-1534
  CrossrefPubMedGoogle Scholar
• 9 Wagner FW. Algoritms of diabetic foot care. In: O’Neil LE. (eds.) The diabetic foot. Second ed. St. Louis: Mosby Year Book; 1983: 291-302
  Google Scholar
• 10 Peters EJ, Lavery LA. International Working Group on the Diabetic, Foot. Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care 2001; 24: 1442-1447
  CrossrefPubMedGoogle Scholar
• 11 Grant WP, Foreman EJ, Wilson AS et al. Evaluation of Young’s modulus in Achilles tendons with diabetic neuroarthropathy. J Am Podiatr Med Assoc 2005; 95: 242-246
  CrossrefPubMedGoogle Scholar
• 12 Reddy GK, Stehno-Bittel L, Enwemeka CS. Glycation-induced matrix stability in the rabbit achilles tendon. Arch Biochem Biophys 2002; 399: 174-180
  CrossrefPubMedGoogle Scholar
• 13 Reddy GK. Cross-linking in collagen by nonenzymatic glycation increases the matrix stiffness in rabbit achilles tendon. Exp Diabesity Res 2004; 5: 143-153
  CrossrefPubMedGoogle Scholar
• 14 Reddy GK. Glucose-mediated in vitro glycation modulates biomechanical integrity of the soft tissues but not hard tissues. J Orthop Res 2003; 21: 738-743
  CrossrefPubMedGoogle Scholar
• 15 Zimny S, Schatz H, Pfohl M. The role of limited joint mobility in diabetic patients with an at-risk foot. Diabetes Care 2004; 27: 942-946
  CrossrefPubMedGoogle Scholar
• 16 Holstein P, Lohmann M, Bitsch M et al. Achilles tendon lengthening, the panacea for plantar forefoot ulceration?. Diabetes Metab Res Rev 2004; 20 (Suppl. 01) S37-S40
  CrossrefPubMedGoogle Scholar
• 17 Reihsner R, Pfeiler W, Menzel EJ. Comparison of normal and in vitro aging by non-enzymatic glycation as verified by differential scanning calorimetry. Gerontology 1998; 44: 85-90
  CrossrefPubMedGoogle Scholar
• 18 Boivin GP, Elenes EY, Schultze AK et al. Biomechanical properties and histology of db/db diabetic mouse Achilles tendon. Muscles Ligaments Tendons J 2014; 4: 280-284
  PubMedGoogle Scholar